Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hormone showdown: which progestin best tames uterine cancer before surgery?

NCT ID NCT07436793

First seen Feb 28, 2026 · Last updated Jun 09, 2026 · Updated 16 times

Summary

This study compares two hormone drugs (megestrol acetate and micronized progesterone) in 140 women with endometrial cancer or precancer. Participants take one of the drugs for a short time before their scheduled surgery. Researchers will measure how well each drug slows cancer cell growth and look for clues about why one might work better. The goal is to improve hormone therapy for this type of cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Iowa/Holden Comprehensive Cancer Center

    Iowa City, Iowa, 52242, United States

    Contact Email: •••••@•••••

    Contact

  • University of New Mexico Cancer Center

    Albuquerque, New Mexico, 87106, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of Utah Sugarhouse Health Center

    Salt Lake City, Utah, 84106, United States

    Contact Email: •••••@•••••

    Contact

  • University of Virginia Cancer Center

    Charlottesville, Virginia, 22908, United States

    Contact Email: •••••@•••••

    Contact

Conditions

The condition(s) this trial relates to.

endometrial endometrioid adenocarcinoma Endometrial Hyperplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.